Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Chronic Kidney Disease | Research article

Quality of life among patients with moderate to advanced chronic kidney disease in Ghana - a single centre study

Authors: Elliot K. Tannor, Betty R. Norman, Kwame K. Adusei, Fred S. Sarfo, Mogamat R. Davids, George Bedu-Addo

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

The prevalence of chronic kidney disease (CKD) is increasing worldwide and in Africa. Health related quality of life (QOL) has become an essential outcome measure for patients with CKD and end stage renal disease (ESRD). There is growing interest worldwide in QOL of CKD patients but paucity of data in Ghana. This study sought to assess QOL in patients with moderate to advanced CKD (not on dialysis) and establish its determinants.

Methods

We conducted a cross sectional observational study at the renal outpatient clinic at Komfo Anokye Teaching Hospital (KATH). We collected demographic, clinical and laboratory data. A pretested self-administered Research and Development corporation (RAND®) 36-Item Health Survey questionnaire was administered and QOL scores in physical component summary (PCS) and mental component summary (MCS) were computed. Determinants of QOL were established by simple and multiple linear regression. P value of < 0.05 was considered statistically significant.

Results

The study included 202 patients with CKD not on dialysis. There were 118(58.5%) males. Mean age was 46.7 ± 16.2 years. The majority, 165(81.7%) of patients were on monthly salaries of less than GHS 500 (~USD 125). Chronic glomerulonephritis was the most common cause of CKD in 118 (58.5%) patients followed by diabetes mellitus in 40 (19.8%) patients and hypertension in 19 (9.4%) patients. The median serum creatinine was 634.2 μmol/L (IQR 333–1248) and the median eGFR was 7 ml/min/1.73m2 (IQR 3–16). The most common stage was CKD stage 5 accounting for 143 (71.1%), followed by CKD stage 4 with 45 (22.4%) of cases and 13 (6.5%) of CKD stage 3. The overall mean QOL score was 40.3 ± 15.4. MCS score was significantly lower than PCS score (37.3 ± 10.8 versus 43.3 ± 21.6, P < 0.001). Multiple linear regression showed that low monthly income (p = 0.002) and low haemoglobin levels (p = 0.003) were predictive of overall mean QOL.

Conclusion

Patients with moderate to advanced CKD had low-income status, presented with advanced disease and had poor QOL. Anaemia and low-income status were significantly associated with poor QOL.
Literature
1.
go back to reference Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.CrossRef Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.CrossRef
2.
go back to reference Seck SM, Diallo IM, Diagne SIL. Epidemiological patterns of chronic kidney disease in black African elders: a retrospective study in West Africa. Saudi J Kidney Dis Transpl. 2013;24:1068.CrossRef Seck SM, Diallo IM, Diagne SIL. Epidemiological patterns of chronic kidney disease in black African elders: a retrospective study in West Africa. Saudi J Kidney Dis Transpl. 2013;24:1068.CrossRef
3.
go back to reference Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med. 2010;268:456–67.CrossRef Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med. 2010;268:456–67.CrossRef
4.
go back to reference Stanifer JW, Jing B, Tolan S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e174–e81.CrossRef Stanifer JW, Jing B, Tolan S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e174–e81.CrossRef
5.
go back to reference Pakasa NM, Sumaili EK. The nephrotic syndrome in the Democratic Republic of Congo. N Engl J Med. 2006;354:1085–6.CrossRef Pakasa NM, Sumaili EK. The nephrotic syndrome in the Democratic Republic of Congo. N Engl J Med. 2006;354:1085–6.CrossRef
6.
go back to reference Li W, Liu L, Puente JG, et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens. 2005;23:1667–76.CrossRef Li W, Liu L, Puente JG, et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens. 2005;23:1667–76.CrossRef
7.
go back to reference Wang R, Zhao Y, He X, et al. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health. 2009;123:534–9.CrossRef Wang R, Zhao Y, He X, et al. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health. 2009;123:534–9.CrossRef
8.
go back to reference The World Health Organization Quality of Life Assessment. (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46:1569–85.CrossRef The World Health Organization Quality of Life Assessment. (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46:1569–85.CrossRef
9.
go back to reference Fructuoso M, Castro R, Oliveira L, Prata C, Morgado T. Quality of life in chronic kidney disease. Nefrologia. 2011;31:91–6.PubMed Fructuoso M, Castro R, Oliveira L, Prata C, Morgado T. Quality of life in chronic kidney disease. Nefrologia. 2011;31:91–6.PubMed
10.
go back to reference Callahan D. The WHO Definition of Health. Hastings Center Studies. 1973;1(3):77–87. Callahan D. The WHO Definition of Health. Hastings Center Studies. 1973;1(3):77–87.
11.
go back to reference Fayers PM, Machin D. Scores and measurements: validity, reliability, sensitivity. In: Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2nd ed; 2007. p. 77–108.CrossRef Fayers PM, Machin D. Scores and measurements: validity, reliability, sensitivity. In: Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2nd ed; 2007. p. 77–108.CrossRef
12.
go back to reference Batlle D, Ramadugu P, Soler M. Progress in retarding the progression of advanced chronic kidney disease: grounds for optimism. Kidney Int. 2006;70:S40–S4.CrossRef Batlle D, Ramadugu P, Soler M. Progress in retarding the progression of advanced chronic kidney disease: grounds for optimism. Kidney Int. 2006;70:S40–S4.CrossRef
13.
go back to reference Alston H. Conservative care for end-stage kidney disease: joint medical conference with the Renal Association, British Geriatrics Society and Association for Palliative Medicine. Clin Med. 2013;13:383–6.CrossRef Alston H. Conservative care for end-stage kidney disease: joint medical conference with the Renal Association, British Geriatrics Society and Association for Palliative Medicine. Clin Med. 2013;13:383–6.CrossRef
14.
go back to reference Boima V, Ganu V, Adjei D, et al. Psychological wellbeing and quality of life among chronic kidney disease patients in Ghana. In: Changing trends in mental health care and research in Ghana; 2015. Boima V, Ganu V, Adjei D, et al. Psychological wellbeing and quality of life among chronic kidney disease patients in Ghana. In: Changing trends in mental health care and research in Ghana; 2015.
15.
go back to reference Moosa M, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int. 2006;70:1107–14.CrossRef Moosa M, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int. 2006;70:1107–14.CrossRef
16.
go back to reference Lee MB, Bargman JM. Survival by Dialysis Modality-Who Cares? Clin J Am Soc Nephrol. 2016;11(6):1083–7.CrossRef Lee MB, Bargman JM. Survival by Dialysis Modality-Who Cares? Clin J Am Soc Nephrol. 2016;11(6):1083–7.CrossRef
17.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–70.CrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–70.CrossRef
18.
go back to reference National KF. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1. National KF. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1.
19.
go back to reference Locatelli F, Nissenson AR, Barrett BJ, et al. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2008;74:1237–40.CrossRef Locatelli F, Nissenson AR, Barrett BJ, et al. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2008;74:1237–40.CrossRef
20.
go back to reference Hays RD, Amin N, Leplege A, et al. Kidney disease quality of life short form (KDQOL-SFtm), version 1.2: a manual for use and scoring (French Questionnaire, France). Santa Monica: RAND; 1997. Hays RD, Amin N, Leplege A, et al. Kidney disease quality of life short form (KDQOL-SFtm), version 1.2: a manual for use and scoring (French Questionnaire, France). Santa Monica: RAND; 1997.
21.
go back to reference Ware JE, Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA project. J Clin Epidemiol. 1998;51:1167–70.CrossRef Ware JE, Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA project. J Clin Epidemiol. 1998;51:1167–70.CrossRef
22.
go back to reference StataCorp. Stata 13 Survival Analysis and Epidemiological Tables Reference Manual. College Station: Stata Press; 2014. StataCorp. Stata 13 Survival Analysis and Epidemiological Tables Reference Manual. College Station: Stata Press; 2014.
23.
go back to reference Amoako YA, Laryea DO, Bedu-Addo G, Andoh H, Awuku YA. Clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. Pan Afr Med J. 2014;18(274). Amoako YA, Laryea DO, Bedu-Addo G, Andoh H, Awuku YA. Clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. Pan Afr Med J. 2014;18(274).
24.
go back to reference Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease a meta-analysis. J. Am Soc Nephrol. 2000;11(2):319–29. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease a meta-analysis. J. Am Soc Nephrol. 2000;11(2):319–29.
25.
go back to reference Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis. 1995;25:515–33.CrossRef Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis. 1995;25:515–33.CrossRef
26.
go back to reference Fox CS, Larson MG, Vasan RS, et al. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol. 2006;17:521–7.CrossRef Fox CS, Larson MG, Vasan RS, et al. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol. 2006;17:521–7.CrossRef
27.
go back to reference Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam study. Arch Intern Med. 2005;165:2659–65.CrossRef Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam study. Arch Intern Med. 2005;165:2659–65.CrossRef
28.
go back to reference Zhang Q-L, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117.CrossRef Zhang Q-L, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117.CrossRef
29.
go back to reference Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the renal research institute-CKD study. Am J Kidney Dis. 2005;45:658–66.CrossRef Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the renal research institute-CKD study. Am J Kidney Dis. 2005;45:658–66.CrossRef
30.
go back to reference Masina T, Chimera B, Kamponda M, Dreyer G. Health related quality of life in patients with end stage kidney disease treated with haemodialysis in Malawi: a cross sectional study. BMC Nephrol. 2016;17:61.CrossRef Masina T, Chimera B, Kamponda M, Dreyer G. Health related quality of life in patients with end stage kidney disease treated with haemodialysis in Malawi: a cross sectional study. BMC Nephrol. 2016;17:61.CrossRef
31.
go back to reference Alvares J, Cesar CC, Acurcio Fde A, Andrade EI, Cherchiglia ML. Quality of life of patients in renal replacement therapy in Brazil: comparison of treatment modalities. Qual Life Res. 2012;21:983–91.CrossRef Alvares J, Cesar CC, Acurcio Fde A, Andrade EI, Cherchiglia ML. Quality of life of patients in renal replacement therapy in Brazil: comparison of treatment modalities. Qual Life Res. 2012;21:983–91.CrossRef
33.
go back to reference Antwi S. State of renal replacement therapy services in Ghana. Blood Purif. 2015;39:137–40.CrossRef Antwi S. State of renal replacement therapy services in Ghana. Blood Purif. 2015;39:137–40.CrossRef
34.
go back to reference Dowling TC. Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview. Am J Health Syst Pharm. 2007;64. Dowling TC. Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview. Am J Health Syst Pharm. 2007;64.
35.
go back to reference Erslev A. Humoral regulation of red cell production. Blood. 1953;8:349–57.PubMed Erslev A. Humoral regulation of red cell production. Blood. 1953;8:349–57.PubMed
36.
go back to reference Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis. 2010;55:726–41.CrossRef Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis. 2010;55:726–41.CrossRef
37.
go back to reference Fudin R, Jaichenko J, Shostak A, Bennett M, Gotloib L. Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study. Nephron. 1998;79:299–305.CrossRef Fudin R, Jaichenko J, Shostak A, Bennett M, Gotloib L. Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study. Nephron. 1998;79:299–305.CrossRef
38.
go back to reference National KF. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47:S11.CrossRef National KF. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47:S11.CrossRef
39.
go back to reference Winearls C, Pippard M, Downing M, Oliver D, Reid C, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986;328:1175–8.CrossRef Winearls C, Pippard M, Downing M, Oliver D, Reid C, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986;328:1175–8.CrossRef
40.
go back to reference Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med. 1987;316:73–8.CrossRef Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med. 1987;316:73–8.CrossRef
41.
go back to reference Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis. 1999;33:821–8.CrossRef Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis. 1999;33:821–8.CrossRef
42.
go back to reference Kimel M, Leidy NK, Mannix S, Dixon J. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease. Value Health. 2008;11:57–75.CrossRef Kimel M, Leidy NK, Mannix S, Dixon J. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease. Value Health. 2008;11:57–75.CrossRef
43.
go back to reference Leaf DE, Goldfarb DS. Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int. 2009;75:15–24.CrossRef Leaf DE, Goldfarb DS. Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int. 2009;75:15–24.CrossRef
44.
go back to reference Drüeke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071–84.CrossRef Drüeke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071–84.CrossRef
45.
go back to reference Kalantar-Zadeh K, McAllister CJ, Lehn RS, Liu E, Kopple JD. A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis. 2004;43:671–84.CrossRef Kalantar-Zadeh K, McAllister CJ, Lehn RS, Liu E, Kopple JD. A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis. 2004;43:671–84.CrossRef
46.
go back to reference Kamal NN, Kamel EG, Eldessouki KH, Ahmed MG. Health-related quality of life among hemodialysis patients at El-Minia University Hospital, Egypt. J Public Health. 2013;21:193–200.CrossRef Kamal NN, Kamel EG, Eldessouki KH, Ahmed MG. Health-related quality of life among hemodialysis patients at El-Minia University Hospital, Egypt. J Public Health. 2013;21:193–200.CrossRef
47.
go back to reference Ashuntantang G, Osafo C, Olowu WA, et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob Health. 2017;5(4):408–17.CrossRef Ashuntantang G, Osafo C, Olowu WA, et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob Health. 2017;5(4):408–17.CrossRef
48.
go back to reference Suet-Ching WL. The quality of life for Hong Kong dialysis patients. J Adv Nurs. 2001;35:218–27.CrossRef Suet-Ching WL. The quality of life for Hong Kong dialysis patients. J Adv Nurs. 2001;35:218–27.CrossRef
49.
go back to reference Liem YS, Bosch JL, Hunink MM. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008;11:733–41.CrossRef Liem YS, Bosch JL, Hunink MM. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008;11:733–41.CrossRef
50.
go back to reference Bakewell AB, Higgins RM, Edmunds ME. Quality of life in peritoneal dialysis patients: decline over time and association with clinical outcomes. Kidney Int. 2002;61:239–48.CrossRef Bakewell AB, Higgins RM, Edmunds ME. Quality of life in peritoneal dialysis patients: decline over time and association with clinical outcomes. Kidney Int. 2002;61:239–48.CrossRef
51.
go back to reference Czyzewski L, Sanko-Resmer J, Wyzgal J, Kurowski A. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant. 2014;19:576–85.CrossRef Czyzewski L, Sanko-Resmer J, Wyzgal J, Kurowski A. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant. 2014;19:576–85.CrossRef
Metadata
Title
Quality of life among patients with moderate to advanced chronic kidney disease in Ghana - a single centre study
Authors
Elliot K. Tannor
Betty R. Norman
Kwame K. Adusei
Fred S. Sarfo
Mogamat R. Davids
George Bedu-Addo
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1316-z

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue